NDC 10481-3006

SODIUM HYDROXIDE

Sodium Hydroxide

SODIUM HYDROXIDE is a Topical Liquid in the Human Prescription Drug category. It is labeled and distributed by Gordon Laboratories. The primary component is Sodium Hydroxide.

• Product ID: 10481-3006_b92631c2-5e63-4526-acdc-a2940145407b
• NDC: 10481-3006
• Product Type: Human Prescription Drug
• Proprietary Name: SODIUM HYDROXIDE
• Generic Name: Sodium Hydroxide
• Dosage Form: Liquid
• Route of Administration: TOPICAL
• Marketing Start Date: 2010-07-16
• Marketing Category: UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
• Labeler Name: Gordon Laboratories
• Substance Name: SODIUM HYDROXIDE
• Active Ingredient Strength: 0 g/g
• Pharm Classes: Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA]
• NDC Exclude Flag: E
• Listing Certified Through: 2017-12-31

Packaging

NDC 10481-3006-1

59 g in 1 BOTTLE, GLASS (10481-3006-1)

• Marketing Start Date: 2010-07-16
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 10481-3006-1 [10481300601]

SODIUM HYDROXIDE LIQUID

• Marketing Category: unapproved drug other
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2010-07-16
• Inactivation Date: 2019-10-29

Drug Details

Active Ingredients

Ingredient	Strength
SODIUM HYDROXIDE	.01 g/g

OpenFDA Data

• SPL SET ID: cb72936e-d185-4e18-8d59-01d07098c46b
• Manufacturer:
  • Gordon Laboratories
• UNII:
  • 55X04QC32I
• RxNorm Concept Unique ID - RxCUI:
  • 238470
• UPC Code:
  • 0850217001853

Pharmacological Class

• Osmotic Laxative [EPC]
• Increased Large Intestinal Motility [PE]
• Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
• Osmotic Activity [MoA]